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Abstract.  The mechanisms involved in the targeting 
of proteins to different cytosolic compartments are still 
largely unknown. In this study we have investigated 
the targeting signal of the 65-kD isoform of glutamic 
acid decarboxylase (GAD65), a major autoantigen in 
two autoimmune diseases: Stiff-Man syndrome and 
insulin-dependent diabetes mellitus. GAD65 is ex- 
pressed in neurons and in pancreatic/~-cells, where it 
is concentrated in the Golgi complex region and in 
proximity to GABA-containing vesicles. GAD65, but 
not the similar isoform GAD67 which has a more 
diffuse cytosolic distribution, is palmitoylated within 
its first 100 amino acids (a.a.). We have previously 
demonstrated that the domain corresponding to a.a. 
1-83 of GAD65 is required for the targeting of GAD65 
to the Golgi complex region. Here we show that this 
domain is sufficient to target an unrelated protein, 
/~-galactosidase,  to the same region. Site-directed 
mutagenesis of all the putative acceptor sites for thio- 
palmitoylation within this domain did not abolish tar- 
geting of GAD65 to the Golgi complex region. The 
replacement of a.a.  1-29 of GAD67 with the corre- 
sponding a.a.  1-27 of GAD65 was sufficient to target 
the otherwise soluble GAD67 to the Golgi complex 
region. Conversely, the replacement of a.a.  1-27 of 
GAD65 with a.a.  1-29 of GAD67 resulted in a 
GAD65 protein that had a diffuse cytosolic distribu- 
tion and was primarily hydrophilic, suggesting that tar- 
geting to the Golgi complex region is required for 
palmitoylation of GAD65. We propose that the domain 
corresponding to a.a.  1-27 of GAD65, contains a sig- 
nal required for the targeting of GAD65 to the Golgi 
complex region. 
T 
HE  identification  of the signals  responsible  for the 
sorting  of proteins to distinct  intraceUular compart- 
ments is an important step towards the elucidation of 
the complex architecture of the cell. While signals responsi- 
ble for the targeting of proteins from the cytosolic compart- 
ment into membranous organelles have been extensively in- 
vestigated,  little  is  known about the targeting  signals  of 
cytosolic peripheral membrane proteins and cytosolic ma- 
trix proteins.  Fatty acylation,  including  palmitoylation  on 
cysteine residues,  is one of the mechanisms involved in the 
targeting of cytosolic proteins to membranes (Chow et al., 
1992). Palmitoylation  is thought to mediate membrane as- 
sociation of several neuronal proteins which are enriched in 
axons  and growth cones.  These include GAP-43 (growth 
cone-associated protein of 43 kD) (Skene and Virag;  1989; 
Liu et al., 1991), a protein which plays a role in axon growth 
(Skene,  1989), SNAP-25 (synaptosomal-associated  protein 
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of 25 kD) (Hess et al.,  1992), a plasmalemma-associated 
protein involved in exocytosis from neurons (Oyler et al., 
1989;  Stllner et al.,  1993),  and GAD65  (glutamic  acid 
decarboxylase of 65 kD) (Christgau et al., 1992), the enzyme 
which synthesizes  the inhibitory neurotransmitter GABA 
(Erlander and Tobin,  1991). 
In  mammals,  glutamic  acid  decarboxylase (GAD) t  is 
represented by two different  isoforms defined as GAD67 and 
GAD65 according to their molecular masses of 67 and 65 
kD, respectively (Kobayashi et al.,  1987; Erlander et al., 
1991). The two GAD isoforms are highly conserved in evolu- 
tion and exhibit a substantial degree of  homology (64% iden- 
tity in the rat). Neither GAD65 nor GAD67 have putative 
transmembrane regions (Erlander and Tobin,  1991). 
They differ considerably only in the NH2-terminal por- 
tion (a.a.  1-100)-a region which does not appear to be es- 
sential for the catalytic activity of the molecule (Erlander et 
al., 1991). GAD65 and GAD67 are coexpressed in the large 
majority of GABA-secreting neurons (Erlander and Tobin, 
1991), pancreatic islets (Vincent et al.,  1983; Reetz et al., 
1. Abbreviations used in thispaper: a.a., amino acids; GAD, glutamic acid 
decarboxylase; GAD65,  65 kD isoform of glutamic acid decarboxylase; 
GAD67, 67 kD isoform of glutamic acid deearboxylase. 
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other cell types (Erd6 et al., 1990; Persson et al., 1990; Til- 
lakaratne et al.,  1992).  GAD65, is the dominant autoanti- 
gens in two human autoimmune diseases:  Stiff-Man Syn- 
drome, a rare neurological disease (Solimena et al.,  1988, 
1990;  Butler et al.,  1993;  Bj6rk et al., 1994);  and insulin- 
dependent diabetes mellitus (Solimena et al.,  1990;  Baek- 
keskov et al.,  1990;  Hagopian et al.,  1993;  Richter et al., 
1993;  Velloso et al.,  1993). 
Although very similar, GAD65 and GAD67 have a par- 
tially different intracelhlar distribution. In neurons, GAD65 
is enriched in nerve terminals (Kaufman et al., 1991) where 
a  pool of the protein is associated with synaptic vesicles 
(Reetz et al., 1991). GAD67, on the other hand, has a more 
diffuse distribution throughout the neuronal cytosol (Kauf- 
man et al., 1991). In pancreatic/~-cells GAD65 is primarily 
concentrated in the region of the Golgi complex (Reetz et 
al.,  1991; Sorenson et al.,  1991) and in close proximity to 
synaptic-like microvesicles (Reetz et al., 1991; Christgau et 
al.,  1992).  Subcellular fractionation studies carded out in 
pancreatic islets have demonstrated that GAD65 is partially 
recovered in particulate fractions, while GAD67 is recovered 
in soluble fractions (Christgau et al., 1991). The differential 
targeting of the two GAD isoforms has also been observed 
in fibroblasts independently transfected with GAD65  and 
GAD67. In these cells GAD65 was concentrated in the Golgi 
complex region and was partially recovered in particulate 
fractions  in  subcellular  fractionation experiments,  while 
GAD67 was found homogeneously distributed throughout 
the cell cytosol and was recovered only in soluble fractions 
(Solimena et al.,  1993). 
The limited primary sequence divergence between GAD65 
and GAD67 facilitates the identification of signal(s) involved 
in the targeting of GAD65 to subcellular structures. Studies 
carded out in pancreatic islets and insect Sf9 cells trans- 
fected with GAD65 have shown that GAD65 undergoes two 
hydrophobic posttranslational modifications within its first 
100  a.a.  One of the  two modifications was  identified as 
palmitoylation sensitive to hydroxylamine  treatment at pH 8 
(Christgau et al., 1992),  a result suggestive of a thio-esther 
linkage (James  and Olson,  1990;  Masterson and Magee, 
1991).  Proteolytic removal of this NH2-terminal region of 
GAD65 led to a  complete solubilization of the remaining 
fragment, suggesting that the recovery of GAD65 in particu- 
late fractions was due to an association of the protein with 
membranes mediated by a  lipid anchor (Christgau et al., 
1992).  When CHO cells were transfected with a construct 
in which the NH2-terminal region of rat GAD67 (a.a.  1-88) 
was replaced by the corresponding portion of rat GAD65 
(a.a.  1-83),  the  chimeric  GAD  molecule,  like  wild-type 
GAD65, was concentrated in the region of  the Golgi complex 
(Solimena et al., 1993). This finding suggests that the NH2- 
terminal domain of GAD65 contains information sufficient 
to target the otherwise soluble GAD67 to this intracellular 
compartment. 
In  this  study we have  further defined the mechanisms 
responsible for the intracellular targeting of GAD65.  We 
demonstrate that its NH2-terminal domain (a.a. 1-83) is suf- 
ficient to target an unrelated protein, ~galactosidase, to the 
Golgi complex region. Using site-directed mutagenesis, we 
show that thioacylation  is not required for the targeting of the 
protein to this cellular region. In addition, we demonstrate 
that a domain corresponding to a.a.  1-27 of GAD65, which 
does not include any cysteine, is required to target the other- 
wise  soluble GAD67 to the Golgi complex region.  Con- 
versely, a  chimeric protein in which a.a.  1-27 of GAD65 
were replaced by the corresponding region of GAD67 (a.a. 
1-29) displayed a homogeneously diffuse distribution in the 
cell cytosol. We suggest that a.a. 1-27 contain a signal which 
is  necessary for targeting  GAD65  to  the  Golgi complex 
region. 
Materials and Methods 
Antibodies and Cytochemical  Probes 
Rabbit antiserum 7673 raised against the last 17 a.a.  of rat GAD67  and 
which  recognizes  both GAD67  and  GAD65  was  previously  described 
(Solimena et al.,  1993).  The following  antibodies were generous gifts: 
mouse monoclonal antibody GAD6 directed against GAD65 (Dr. D. Gott- 
lieb, St.  Louis,  MO; Chang and Gottlieb, 1988);  rabbit serum directed 
against rat synaptophysin  (Dr. R. Jahn, New Haven, CT) (Navone et al., 
1986);  rabbit serum directed against ~-mannosidase II (Dr.  Moremen, 
Athens, GA) (Moremen and Touster,  1985); rabbit serum directed against 
TGN38 (Dr. Howell,  Denver,  CO) (Jones et al.,  1993). The following re- 
agents were obtained from commercial sources: 1(,2 rabbit antiserum raised 
against recombinant GAD67 (Chemicon, Temecula, CA); mouse monoclo- 
hal antibodies directed against/~-galactosidase  (Promega,  Madison, W1); 
FITC-conjugated  lentil  lectin  (Lens  culinaris)  (EY  Laboratories,  San 
Mateo, CA); secondary antibodies (Jackson Immunoresearch Laboratories, 
West Grove,  PA). 
Generation of  GAD Constructs 
Standard DNA procedures were performed according to Sambrook et al. 
(1989). Cloning of rat GAD65 cDNA was previously described (Solimena 
et al., 1993). The rat GAD67 cDNA was a generous gift of Dr. D. Gottlieb 
(St. Louis, MO) (Wyborski et al., 1990). GAD65 and GAI~7 cDNA were 
excised from Bluescript II SK +/-  (Stratagene,  La Jolla, CA) as HindM- 
NotI (GAD65) and HindM-HindM (GAD67)  fragments and subcloned 
into the pRC/RSV  vector (Invitrogen,  San Diego,  CA) for expression in 
CHO cells. Generation of the fusion protein GAD65(1-83)/GAD67 was pre- 
viously described (Solimena et al., 1993). Site-directed  mutagenesis to re- 
place cysteines With serines at a.a. positions 30, 45, 73, 75, 80, and 82 of 
GAD65 (see Fig. 1) was performed according to PCR procedures previously 
described (Higuchi,  1989).  The  resulting constructs are referred to as 
GAD65 $1, GAD65 $2, etc. (Fig. 1). The same approach was used to gener- 
ate GAD65  $1-6, in which all the cysteines contained within a.a.  1-82 of 
GAI~5 were  replaced  by serines. Similar  PCR procedures, in this  case  using 
overlapping  GAD65/GAD67,  GAD67/GAD65,  and GAD//~-galactosidnse 
fusion primers, were used to generate the following chimeric GAD con- 
structs:  GAD65(I-27)/GAD67,  in which a.a.  1-27 of GAI~5 replaced the 
corresponding region (a.a.  1-29, see Fig.  1)  of GAD67;  GAD65(I-57)/ 
GAD67, in which a.a.  1-57 of GAD65 replaced  the corresponding region 
(a.a. 1-61)  of GAD67; GAD67(I-29)/GAD65,  in which a.a. 1-29 of GAI~7 
replaced the corresponding region (a.a. 1-27) of GAD65; GAD65(1-83)//~- 
galactosidase,  in which a.a. 1-83 of GAD65 were fused to the NH2-termi- 
nus of B-galactosidase.  The ~-galactosidase cDNA was a kind gift of Dr. 
M. Lerner (Yale University,  New Haven,  CT). The sequence of all PCR 
products was confirmed by sequence analysis,  and the resulting constructs 
were subcloned into the pRC/RSV  vector for transfection. 
Hippocampal Cell Cultures 
Primary culture of hippocampal neurons were prepared as previously  de- 
scribed (Banker and Cowan,  1977; Goslin et al.,  1990;  Mundigl et al., 
1993). Cells were plated at the density of 4,000 ×  cm  2 on coverslips and 
grown up to five weeks. 
Stable Transfection of  ClIO Cells 
Cultured CHO cells (Gluzman,  1981; Cameron et al.,  1991) were tran- 
siently or permanently transfected using Lipofectin reagent (GIBCO/BRL, 
Gaithersbuvg, MD) as previously described (Solimena et al., 1993). Stable 
cell lines were cloned by limiting dilution.  After two weeks in selective me- 
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Figure L Schematic drawing illustrating  the GAD constructs inves- 
tigated in this paper. Cysteines which have been replaced  by a serine 
are indicated by a C. (b) Sequence alignment of the NH~-terminal 
region of GAD65 (a.a. 1-95) and GAD67 (a.a. 1-100). Open arrow- 
heads point to each of the 6 cysteines contained within the NH2- 
terminal region of GAD65. Closed arrowheads indicate the position 
at which GAD67 and GAD65 have been spliced to produce chi- 
meric proteins. 
dia (DMEM containing 700 t~g/rul  of G418), transfccted cells were treated 
for 18 h with 10 mM n-butyric acid and screened for level of expression 
of the transfeeted protein by Western blotting. At least three independent 
expressing clones of each construct were analyzed for localization of the 
protein by immunoeytochemistry.  To increase the levels  of  expression  of  the 
transfected protein, cells were incubated with I0 mM n-butyric acid for 
24 h before fixation or homogenization. 
lmmunofluorescence 
Single and double immunofluorescence  staining was performed as previ- 
ously described (Cameron et al., 1991; Solirnena et al., 1993; Mundigl et 
al., 1993). 
Biochemical Procedures 
Subcellular fractionatton. Stably transfected CHO cells were grown to 
confluency. Approximately 8 ×  107 cells were harvested in 15 ml PBS, 5 
mM EDTA, pelleted at 1,000 g for 10' at 4"C and resnspended in 3 ml of 
homogenization  buffer (150 mM NaCI, 20 mM Hepes, pH 7.4 and the fol- 
lowing prolease inhibitor mixture: 1/~g/ml leupeptin, 1 ~g/rni aprotinin, 
t gg/ml pepstatin in methanol, 1 t~g/ml  antipain in ethanol, 1 mM PMSF 
in isopropanol, 10 mM beozamidine). Cells were homogenized with 10 
strokes in a ball bearing homogenizer, bail diameter 0.0016 inches, clear- 
ante 0.0012 inches) (H. Issel Inc., Redwood, CA). Cell homogenates  were 
centrifuged at 3,000 g for lff at 4"C in a refrigerated  microcentrifuge  Sigma 
2K15 (13. Braun, Allentown, PA). 2.5-ml aliquots of the resulting post- 
nuclear supernatants were spun at 100,000 g for 20' at 40C in a TL100.3 
rotor (Beckman  Instruments, Palo Alto, CA). The pellets were resuspended 
to the volume of the original postnuelear supernatant in homogenization 
buffer. High-speed supernatants and resuspended high-speed pellets were 
analyzed  by SDS-PAGE  and immunoblotted  as described (Laemmli, 1970; 
Towbin et al., 1979). 
Triton X.114  assay. The following  protocol was modified from the origi- 
nal procedure described by Bordier (1981). Approximately 8 ×  107 cells 
were washed once with PBS, and then solubillzed in 2 ml solubilization 
buffer consisting  of 150 mM NaCl, 1% precondensed Triton X-114, 20 mM 
Hepes, pH 7.4 and the following protease inhibitors mixture:  1 /~g/ml 
leupeptin; 1 ~g/ml aprotinin, 1 i,g/mi pepstatin in methanol, 1 ~g/ml an- 
tipain in ethanol, 1 mM PMSF in isopropanol, 10 mM banzamidine. The 
detergent extracts were incubated for 1 h at 4°C on a nutator. The Triton 
X-I14 insoluble material was pelleted by centrifngation at 100,000 g, 4"C 
for 30'. 0.5-ml aliqnots of the Triton X-114 soluble material were overlaid 
in  1.5-mi mierocentrifnge tubes onto  0.5  ml  6%  sucrose cushions in 
solubflization  buffer and incubated for 5' at 37"C. After centrifugation at 
13,000 g for 10" at room temperature, the tubes were placed again at 37°C, 
the aqueous fractions removed  (,~900/~1  each) and detergent  phases brought 
back to 1 ml with 150 mM NaCI, 10 mM Hepes, pH 7.4. 100/A 10% Triton 
X-114 was added to each aqueous  phase. Aqueous  and detergent  phases were 
analyzed by SDS-PAGE  and immunoblotted. Immunoreactivity  in Western 
blots was revealed  either by enhanced chemiluminescence  detection accord- 
ing to manufacturer's instruction (Amersham Corp.,  Arlington Heights, 
IL), or by ]25I-protein  A (Du Pont New England Nuclear, Boston, MA) 
and autoradiography. 
Scanning and densitometry of the autoradiograms was performed using 
the Bio Image program on a Visage 2000 scanner (Millipore Corp., Bed- 
ford, MA). 
Results 
A Pool of GAD65 Is Localized at the Golgi 
Complex Region in Neurons 
In this study we have investigated the mechanisms responsi- 
ble for the targeting of GAD65 to the region of the Golgi 
complex. This localization was previously demonstrated in 
pancreatic 13-cells, which endogenously express the protein 
(Reetz et al., 1991), as well as in transfected CHO and COS 
cells (Solimena et al., 1993). To establish whether a pool of 
GAD65 is also concentrated at the Golgi complex region of 
neuronal cells, we studied the localization of the protein in 
cultured rat hippocampal neurons. In these cultures pyrami- 
dai  neurons  account  for  the  majority  of the  ceils,  while 
GABA-ergic neurons,  which express high level of GAD65, 
comprised '~7 %  of the neuronal population (Craig et al., 
1993).  GAD65  immunoreactivity became  detectable after 
two weeks in culture and progressively increased both in the 
cell soma and in the axonal processes (data not shown).  In 
all GABA-ergic neurons  after  5  wk  in  culture,  a  pool of 
GAD65 was colocalized with TGN38,  a  marker protein of 
the Golgi complex (Luzio et al., 1990) (Fig. 2 b). Prominent 
GAD65 immunoreactivity was also visible in the presynaptic 
axonal varicosities of the same neurons, where synaptic vesi- 
cles are clustered. 
The NHrterminal Region of GAD65 Is Sufficient 
to Target a GAD-unrelated Protein to the Region of 
the Goigi Complex 
We have previously shown that the replacement of a.a.  1-88 
of GAD67 with a.a. 1-83 of GAD65 is sufficient to target the 
otherwise soluble GAD67 to the region of  the Golgi complex 
(Solimena et al., 1993).  This experiment demonstrated that 
Solimena et al. GAD65 Targeting to the Golgi Complex  333 Figure 2. Color micrograph showing the localization of  GAD65 in the Golgi complex of  a hiplxwannpal neuron in primary culture. Neurons 
from a 5-wk old culture were double-labeled for GAD65 with the GAD65-specific monoclonal antibody GAD6 (a, red  fluorescence) and 
for the Golgi marker TGN38 (b, green  fluorescence) GAD65 and TGN 38 immunoreactivities precisely coincide in the region of the Golgi 
complex, c shows a superimposition of the two staining patterns. GAD65 and TGN 38 immunoreactivities precisely coincide in the region 
of  the Golgi complex (yellowfluorescence  in c). In addition, GAD65 is also concentrated in presynaptic varicosities of  axons which innervate 
the perikarya dendrities of the neuron. Bar, 17 ~m. 
the NH2-terminal region of GAD65 is required for its intra- 
cellular sorting. However, it did not rule out the possibility 
that some features conserved between the two GAD isoforms 
may act in concert with the NH2-terminal domain of GAD65 
to determine its subcellular targeting. To rule out this possi- 
bility, we tested whether a.a.  1-83 are sufficient to target an 
unrelated protein, B-galactosidase, to the same intracellular 
compartment as GAD65. CHO cells were transiently trans- 
fected either with  /3-galactosidase or  with  the  GAD65(1- 
83)//3-galactosidase fusion protein,  in  which  a.a.  1-83 of 
GAD-65 were linked to the NH2 terminus of/3-galactosi- 
dase. While/3-galactosidase had a diffuse cytosolic localiza- 
tion (Fig.  3 a),  GAD65(1-83)//~-galactosidase was concen- 
trated in the region of the Golgi complex (Fig. 3, b and c), 
as demonstrated by its colocalization with a Golgi marker 
(lentil lectin-binding sites, Ridgway et al.,  1992) (compare 
Fig.  3 c with Fig. 3 d). 
Targeting of  GAD65 to the Golgi Complex Region 
Does Not Depend on Thio-Palmitoylation 
Palmitic acid bound to the NH2-terminal region of GAD65 
can be removed by treatment with hydroxylamine at pH 8.0 
(Christgau et al.,  1992). This finding suggests a binding of 
the fatty acid mediated by a thio-esther linkage (James and 
Olson,  1990; Masterson and Magee,  1991).  Having estab- 
lished that a.a.  1-83 of GAD65  contains the information 
which is necessary and sufficient to target a protein to the 
Golgi complex region, we investigated whether preventing 
thio-acylation within this domain would affect the protein's 
intraceUular distribution. This region of GAD65 contains 6 
cysteines at positions 30, 45, 73, 75,  80, and 82 (Fig.  1 b). 
To test the role of thio-acylation in GAD65 targeting,  we 
generated CHO cell lines that stably express GAD65 con- 
structs in which each of the 6 cysteines was replaced by ser- 
ine residues (Fig.  1). All the constructs harboring a  single 
point mutation were still targeted to Golgi complex region, 
as demonstrated by their colocalization with Golgi markers 
including lentil lectin-binding sites (not shown) and ot-man- 
nosidase U (Moremen and Touster, 1985) (Fig. 4). Since pal- 
mitoylation may in principle occur on more than one cysteine 
simultaneously, we also generated cell lines permanently ex- 
pressing GAD65 S1-6, a GAD65 mutant in which all of the 
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Figure 3. Intracellular distribution of  #-galactosidase  and of GAI~5(1-83)//3-galactosidase  in transiently transfeeted  CHO cells. Cells trans- 
fected with/5-galactosidase.  Cells transfeeted with GAD65(1-83)/13-galaetosidase,/3-galactosidase  has a diffuse cytosolic distribution while 
GAD65(1-83)//3-glactosidase is concentrated in the region of the Golgi complex. Shows eounterstaining of the field shown in GAD65(1- 
83)//5-galactosidase with FITC-labeled lentil lectin, a lectin which specifically binds to the Golgi complex region. Only one of the cells 
present in the field expresses GAD65(1-83)//3-galactosidase. Bar, 25 gin. 
6 cysteines were replaced by serines (Fig.  1). A significant 
pool of  the protein was still targeted to the region of  the Golgi 
complex (Fig. 5). These findings suggest that thio-palmitoy- 
lation of GAD65 is not required for the targeting of GAD65 
to the Golgi complex region. 
Amino Acids 1-27  of  GAD65 Contain a Signal 
Required for the Targeting of  GAD65 to the Golgi 
Complex Region 
We  next tried  to  further define the domain at the  NH2- 
terminal region of GAD65 responsible for its targeting to the 
Golgi complex region.  Chimeric GAD proteins  in which 
a.a.  1-57 or 1-27 of GAD65 replaced the corresponding re- 
gions in GAD67, i.e., constructs GAD65(1-57)/GAD67  and 
GAD65(1-27)/GAD67,  respectively (Fig. 1 and Fig. 6, a and 
c), were still colocalized with Golgi complex markers in the 
perinuclear region when expressed by stable transfection in 
CHO cells (Fig. 6, b and d). Conversely, replacement of a.a. 
1-27 of GAD65  with the corresponding region of GAD67 
resulted  in  a  chimeric  protein  referred  to  as  GAD67(1- 
29)/GAD65 (Fig. 1 and Fig. 6 e), which has a diffuse cyto- 
plasmic localization resembling that of wild-type GAD67. 
These results indicate that a.a. 1-27 of GAD65 encode a sig- 
nal which is required for the targeting of the protein to the 
area of the Golgi complex. 
Recovery in Particulate Fractions and Hydrophobicity 
of  GAD65 Rely on a.a. 1-27 
To complement our immunofluorescence data,  the distri- 
bution between soluble and particulate fractions of cell ho- 
mogenates for each of the constructs described above was 
analyzed in stably transfected CHO cell lines. As previously 
reported (Solimena et al.,  1993),  virtually all GAD67 was 
recovered in the soluble fraction (high-speed supernatant) of 
the cell homogenate (Fig.  7,  lanes 1  and 2).  In contrast, 
~40 % of GAD65 was recovered in the particulate fraction 
(high-speed pellet) (Fig.  7,  lanes 3  and 4).  All constructs 
which comprised a.a.  1-27 of GAD65,  i.e.,  GAD65  S1-6, 
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protein in which all eysteines located within a.a.  1-100 have been 
replaced by serines (GAI~5 S1-6). Stably transfected cell line in 
which GAD65 S1-6 is expressed by a subpopulation of cells. Cells 
were stained with the monoclonal antibody GAD6 (a) and counter- 
stained with FITC-lentil lectin (b). Bars, 28 ttm. 
GAD65(1-83)/GAD67  and GAD65(1-27)/GAD67  were par- 
tially recovered in pellet fractions although to a lower extent 
than GAD65 (Fig. 7, lanes 5-10).  Conversely, virtually all 
GAD67(1-29)/GAD65  was recovered in the soluble fraction 
(Fig. 7, lanes//and 12). These results, which are in agree- 
ment with immtmofluorescence data, emphasize the crucial 
role of a.a. 1-27 of GAD65 in determining its particulate dis- 
tribution,  although additional  structural  elements beyond 
a.a. 1-27, including thio-acylation, may further contribute to 
membrane association of GAD65. 
The hydrophobicity of the GAD constructs was analyzed 
by the Triton X-114 detergent assay (Fig. 8). In agreement 
with previous studies (Christgau et al.,  1991, 1992;  Soli- 
mena et al., 1993),  GAD67 only partitioned in the aqueous 
phase (Fig. 8, lanes 1 and 2), while GAD65 partitioned in 
roughly equal amounts between the aqueous and the deter- 
gent phase (Fig. 8, lanes 3 and 4). The chimera GAD65(1- 
83)/GAD67 was recovered in both phases (Fig. 8, lanes 7and 
69, although the ratio between detergent and aqueous pools 
of  the protein was lower than in the case of GAD65. This con- 
struct does not contain the region corresponding to a.a. 325- 
355 of  GAD65 which appear to be considerably more hydro- 
phobic than the corresponding region of GAD67 (Karlsen et 
al.,  1991). Palmitoylation of the NH2-terminal  GAD65 frag- 
ment of  this construct may therefore explain its partial hydro- 
phobicity. On the other hand, a similar detergent/aqueous ra- 
tio was observed for GAD65(1-27)/GAD67  (Fig. 7, lanes 9 
and 10). This finding suggests either that a.a. 1-27 may un- 
dergo hydrophobic modification in spite of the absence of 
cysteines in this region, or that this a.a. stretch confers upon 
the adjacent portion of GAD67 the property to become a suit- 
able substrate for thio-acylation. The former possibility is 
supported by the similar recovery in the detergent phase of 
the GAD65 S1-6 and GAD65 (1-27)/GAD67. Taken together 
these findings support the hypothesis that some other hydro- 
phobic modification(s), distinct from thioacylation contribute 
to the hydrophobicity  of  GAD65 (Christgau et al., 1992). Fi- 
nally, virtually all GAD67(1-29)/GAD65  protein, which has 
a  soluble cytosolic intracelldar distribution (Fig.  6  e and 
Fig. 7, lanes 11 and 12), was recovered in the aqueous phase 
(Fig. 8, lanes//and 12). 
Discussion 
In this study we have investigated the molecular mechanisms 
responsible for the differential targeting of two very similar 
proteins, GAD65 and GAD67, within the cell cytosol. The 
removal of all the potential cysteine acceptor site(s) for thio- 
acylation within the domain of GAD65 known to undergo 
palmitoylation did not affect targeting of the protein to the 
Golgi complex region. Conversely, the replacement of a.a. 
1-27 of GAD65  with the corresponding region of GAD67 
abolished  this  localization.  Our  results  indicate  that  the 
NH2-terminal 27 a.a. of GAD65 are required for its target- 
ing to the region of the Golgi complex. With all constructs 
investigated,  results  of immunofluorescence were  always 
consistent with results of subcellular fractionation. All GAD 
proteins which were targeted to the Golgi complex region 
were also partially recovered in pellets after high-speed cen- 
trifugation of cell homogenates, and were at least partially 
hydrophobic. 
Secondary  structure  predictions  using  a  variety of al- 
gorithms (Chou and Fasman, 1978; Rose, 1978; Gamier et 
al.,  1978)  did not reveal structural motifs in a.a.  1-27 of 
GAD65 (for example possibility of an amphiphatic a-helix) 
which may mediate membrane interaction. This region in- 
Figure 4. Gallery of micrographs demonstrating the intracellular localization of wild-type and mutant GAD proteins in transfected CHO 
cell lines stably expressing each of the protein. Each cell line was stained by GAD (TRITC fluorescence) and counterstained with either 
lentil lectin or anti-c~-mannosidase  antibodies (FITC fluorescence) to reveal the morphology of the Golgi complex. GAD65 was stained 
with the GAD65-specific  monoclonal antibody GAD6. GAD67 was stained with the rabbit K2 antibody. (A) GAD67 has a diffuse distribu- 
tion in the cell cytosol. (B) GAD65 is concentrated in the region of the Golgi complex. (C-H) GAD65 mutant proteins with cysteine 
serine point-mutations at each of the cysteine localized within a.a.  1-100 of the molecule (GAD65 S1-GAD65 $6). Bars, 36/zm. 
Solimena et al. GAD65 Targeting to the Golgi Complex  337 Figure 6. Intracellular  distribution in stably transfected cells of GAD6S/GAD67 chimeric proteins. Cells were stained for GAD (antibody 
K2 for fields a  and c; monoclonal antibody GAD6 for field e) and counterstained with FITC-lent~ lectin. (a and b) Cells expressing 
GAD65(1-57)/GAD67.  (c and d) Cells expressing GAD65(1-27)/GAD67.  (e and f) Cells expressing GAD67(1-29)/GAD65. GAD proteins 
containing the NH2-terminai region of GAD65 are colocaiized with lentil lectin in the Golgi complex region. The different morphology 
of the Golgi complex in a  and b, and in c and d, reflects a normal variation of the architecture of the Golgi complex in CHO cells. The 
GAD fusion protein containing the NH2-terminal region of GAD67 has a diffuse distribution in the cytosol. Bars, 22/~m. 
The Journal of Cell Biology, Volume 126, 1994  338 Figure 7. Distribution of GAD67, GAD65, and GAD mutant pro- 
teins in particulate and soluble fractions of stably transfected CHO 
cell homogenates. HSS, high speed supernatants; lISP, high speed 
pellets. The percentage of  each construct in the high speed superna- 
tant and in the high speed pellets, as determined by densitometry, 
was the following:  GAD67, 99/1; GAD65, 63/37; GAD65S1-6, 91/9; 
GAD65 (1-83)/GAD67, 82/18; GAD (1-27)~GAD67, 76/24; GAD67 
(1-29)~GAD65, 97/3. 
Figure 8. Partitioning of GAD67, GAD65, and GAD mutant pro- 
teins in the aqueous (AQ) and detergent phase (DET) after Triton 
X-114 extraction and phase separation. Percentage of each con- 
struct in the aqueous and in the detergent phase, as determined by 
densitometry, were the following: GAD67, 99/1; GAD65, 53/46; 
GAD65 $1-6, 79/21; GAD65 (1-83)~GAD67, 82/18; GAD (1-27)/ 
GAD67, 79/20; GAD67 (1-29)~GAD65, 99/1. 
eludes three prolines. There are at least two possible mecha- 
nisms through which a.a. 1-27 of  GAD65 may target the pro- 
tein to the Golgi complex region. This a.a. stretch may target 
GAD65 via an interaction with a binding protein(s).  Since 
targeting of GAD65 to the region of the Golgi complex oc- 
curs not only in neurons and in pancreatic/~-cells, but also 
in cells that do not express the protein constitutively such as 
fibroblasts, an implication of this hypothesis is that the puta- 
tive GAD65-binding protein(s) should be present in all cells. 
Alternatively, a  hydrophobic posttranslational modifica- 
tion within this region other than thio-palmitoylation could 
be involved. It has been proposed that the hydrophobicity of 
GAD65 is the consequence of two distinct posttranslational 
modifications occurring within a.a.  1-100 of the protein: 
palmitoylation sensitive to hydroxylamine  treatment at pH 8 
and another yet to be characterized hydrophobic modification 
(Christgau et al., 1992).  Sensitivity to hydroxylamine  at pH 
8 strongly suggests that palmitic acid is linked by a thio-esther 
bond (i.e., to cysteine residues)  (James and Olson,  1990; 
Masterson and Magee, 1991). Amino acids 1-100 of GAD65 
contains 6 cysteines at positions 30, 45, 73, 75, 80, and 82. 
Our results are consistent with the occurrence of another 
post-translational  modification in addition to thio-acylation, 
since replacement of all the 6 cysteines decreased, but did 
not abolish, hydrophobicity of the resulting protein. 
An intriguing observation is that virtually no GAD67(1- 
29)/GAD65, which still includes the 6 cysteines, was recov- 
ered in the detergent phase. This finding may have two expla- 
nations. One possibility to explain this finding is that a.a. 
1-27 of GAD67 are required for an efficient recognition of 
GAD65 as a substrate for palmitoylation. Another explana- 
tion, suggested by the diffuse intracellnlar localization of  this 
chimeric protein and by its recovery in the soluble cytosolic 
fraction, is that a.a. 1-27 are necessary to target the protein 
to  sites  where  the  palmitoyltransferase is  localized.  The 
presence of palmitoyltransferase activity in the region of the 
Golgi complex has been reported (Schmidt and Catterall, 
1987).  Interestingly, also in the case of proteins of the RAS 
superfamily, palmitoylation occurs only if the protein con- 
tains another membrane-targeting signal (Hancock et al., 
1989). 
While our data speak against a primary role ofpalmitoyla- 
tion of cysteine(s) residues in the targeting of GAD65 to the 
region of the Golgi complex, and in general to particulate 
fractions, they do not rule out a  role of palmitoylation in 
strengthening the  interaction of GAD65  with  subcellular 
particles,  most likely membranes.  Among the  constructs 
containing a.a. 1-27 of GAD65, the less effective recovery in 
the high speed pellet was indeed observed in the case of 
GAD65  S1-6, in which all the potential acceptor sites for 
thioacylation had been replaced by serines. 
It is of interest in this context to consider the multiple 
localizations of GAD65 in neurons and in/~-cells. In neurons 
GAD65, besides being present in the area of the Golgi com- 
plex, is concentrated in nerve terminals where a pool of the 
protein is colocalized with synaptic vesicles (Reetz et al., 
1991). In pancreatic/S-cells a fraction of GAD65 is present 
in close proximity to  GABA-containlng synaptic-like mi- 
crovesicles  (Reetz  et  al.,  1991). In principle  these other 
localizations may be mediated by the same signal that targets 
GAD65 to the Golgi complex region. Another possibility is 
that GAD65, as a result of its accumulation in the region of 
the Golgi complex, is subsequently delivered to peripheral 
destinations via vesicles originating in this region. Palmitoy- 
lation could be relevant for GAD binding to these vesicles. 
On the other hand, immunocytochemistry of cultured neu- 
rons and of frozen brain sections demonstrate that the local- 
ization of GAD65  in nerve terminals  include,  but is  not 
limited to,  the sites where synaptic vesicles are clustered 
(our  unpublished  observations).  Thus,  an  interaction  of 
GAD with the cytomatrix surrounding these vesicles, rather 
than, or in addition to, an association with synaptic vesicles 
is  possible.  Notably,  virtually no  GAD  is  recovered  on 
purified synaptic vesicles (Reetz et al.,  1991) in spite of the 
observation that a  considerable portion of brain  GAD65 
sediments upon high speed centrifugation (Chang and Gott- 
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leishmania  tubulin:  GSKFWEVIADEHGVDPTGS  [43%] 
II  II::  :11  ::II::: 
=at GAD65  (aa 1-27): MASPGSGFWSFGSEDGSGDPENPGTAR 
I:  II::  III  : II 
human tubulin  beta-5  chain:  GAKFWEVISDEHGIDP  [40%] 
20  30 
Figure 9. Sequence similarity between a.a. 1-27 of  rat GAD65 (cen- 
ter), a.a. 17-35 of  leishmania tubulin (top), and a.a. 17-32  of  human 
tubulin beta-5 chain (bottom). Search in the Swissprotein Database 
for sequences  homologies to a.a.  1-27 of GAD65 was performed 
using the program FASTA (Wilbur and Lipman, 1983).  Bars con- 
nected identical  residues;  dots connected homologous residues. 
Identity scores are indicated on the right. Note that the FASTA pro- 
gram considers residues  at positions 14 (E, GAD65) and 26 (D, 
tubulins)  and at positions 15 (D, GAD65) and 27 (E, tubulins)  as 
identical. 
lieb, 1988) and is hydrophobic (Reetz, A., and P. De Camilii, 
unpublished observations), consistent with an indirect inter- 
action of GAD65 with synaptic vesicle membranes. 
The  property  of  GAD65  to  serve  as  a  substrate  for 
palmitoylation is shared by other cytosolic neuronal proteins 
which are concentrated in axons and axon terminals:  GAP- 
43 and SNAP-25.  These two proteins as well are concen- 
trated  in the  region  of the  Golgi  complex  (Goslin  et al., 
1990; Van Lookeren Campagne et al.,  1992; M. C. Wilson, 
personal communications,  The Scripps Research Institute, 
San Diego,  CA;  our unpublished observations).  As in the 
case of GAD65, the sorting signal of GAP-g3 is localized at 
its  NH2-terminal  region  which  includes  the  two  cysteine 
residues  that  undergo  palmitoylation  (Skene  and  Virag, 
1989; Liu et al.,  1991). However, no homology between the 
NH2-terminal  of GAD65  and GAP-43  has been  found.  In 
the case of SNAP-25, palmitoylation occurs in the region of 
the so-called cysteine quartet localized between a.a.  84-92 
(Hess et al.,  1992) within a short domain that is subjected 
to alternative splicing (Bark,  1993).  The possibility should 
be considered that also in the case of these other proteins, 
palmitoylation may not be the primary targeting  signal.  It 
was shown that thio-palmitoylation of several neuronal and 
nerve terminal proteins including GAP-43 and SNAP-25 is 
reversible in nerve terminals and that the state of palmitoyla- 
tion of a protein can be regulated (Hess et al., 1993). A spon- 
taneous de-acylation of GAD65 was reported in 3-cell ex- 
tracts (Christgau et al.,  1992). 
Search in databases for sequence similarities revealed that 
a.a.  1-27  of GAD65  is  similar  to  a  domain  in  the  NH2- 
terminal  region  of ~-tubulin  (Fig.  9)  which  is  contained 
within one of the most highly conserved ~-tubulin regions 
(a.a.  1-60) (Cleveland and Sullivan,  1985).  In animal cells 
microtubules originate  (minus end)  from the centrosomal 
area, which acts  as  the  microtubule-organizing  center  (Mitch- 
ison and Kirschner, 1984; Bornens et al.,  1987) and as the 
organizer  of  the  structure  of  the  Golgi complex (Tassin  et  al., 
1985). It  is of  interest  that  in the ciliated  epithelial  cells  of 
the fallopian  tubes, another cell  type which endogenously 
expresses GAD65  (Erd6 et al., 1990; Tillakaratne  et al., 
1992), a pool of  the protein  is concentrated at  basal  bodies 
(Erd6 et  al.,  1990; our  unpublished observations)  which are 
the  organizers  for  the  microtubular cytoskeleton  of  the  cilia. 
It  is  possible  that  the similarity  between a domain of/5-tubu- 
fin  and a  domain of  GAD65 may be  related  to  the  localization 
of GAD65  in proximity of  microtubule-organizing centers. 
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